We determined mutations in the BRAF, N-ras, and CDKN2A genes in 27 histologically diverse melanocytic nevi and corresponding surrounding tissues from 17 individuals. Mutations in the BRAF and N-ras gene were found in 22 nevi (81%) from 16 individuals (94%). The predominant BRAF mutation T1799A (V600E) was detected in 18 nevi; 1 nevus had a novel A1781G (D594V) mutation in the same gene and 3 nevi had mutations in codon 61 of the N-ras gene. In 4 individuals both nevi carried a BRAF mutation, whereas in 2 other individuals 1 nevus showed a BRAF mutation and the second nevus had an N-ras mutation. In 2 individuals normal skin distant from nevi showed a BRAF mutation. No mutations were detected in the CDKN2A gene. The mutations in the BRAF and...
There is increasing epidemiologic and molecular evidence that cutaneous melanomas arise through mult...
Ras mutations, preferentially in codon 61 of the N-ras oncogene, are common in human cutaneous melan...
<div><p>According to the prevailing multistep model of melanoma development, oncogenic BRAF or NRAS ...
We determined mutations in the BRAF, N-ras, and CDKN2A genes in 27 histologically diverse melanocyti...
To investigate whether the frequency of the BRAFV600E (V-raf murine sarcoma virus oncogene homolog B...
Cutaneous melanomas arise through causal pathways involving interplay between exposure to UV radiati...
A single-point mutation in exon 15 of the BRAF gene has recently been reported in a high percentage ...
Melanocytic nevi are thought to be senescent clones of melanocytes that have acquired an oncogenic B...
Most melanocytic nevi develop on sun-exposed skin during childhood and adolescence and commonly harb...
BRAF(V600E) mutations are frequent in melanomas originating from intermittently sun-exposed skin and...
BRAFV600E mutations are frequent in melanomas originating from intermittently sun-exposed skin and a...
The RAS/mitogen-activated protein ki-nase pathway sends external growth-promoting signals to the nuc...
Genetic studies of melanocytic tumors have mainly demonstrated activation of oncogenes such as NRAS ...
Frequent somatic mutation of v-raf murine sarcoma viral oncogene homolog B (BRAF), a downstream effe...
There is increasing epidemiologic and molecular evidence that cutaneous melanomas arise through mult...
There is increasing epidemiologic and molecular evidence that cutaneous melanomas arise through mult...
Ras mutations, preferentially in codon 61 of the N-ras oncogene, are common in human cutaneous melan...
<div><p>According to the prevailing multistep model of melanoma development, oncogenic BRAF or NRAS ...
We determined mutations in the BRAF, N-ras, and CDKN2A genes in 27 histologically diverse melanocyti...
To investigate whether the frequency of the BRAFV600E (V-raf murine sarcoma virus oncogene homolog B...
Cutaneous melanomas arise through causal pathways involving interplay between exposure to UV radiati...
A single-point mutation in exon 15 of the BRAF gene has recently been reported in a high percentage ...
Melanocytic nevi are thought to be senescent clones of melanocytes that have acquired an oncogenic B...
Most melanocytic nevi develop on sun-exposed skin during childhood and adolescence and commonly harb...
BRAF(V600E) mutations are frequent in melanomas originating from intermittently sun-exposed skin and...
BRAFV600E mutations are frequent in melanomas originating from intermittently sun-exposed skin and a...
The RAS/mitogen-activated protein ki-nase pathway sends external growth-promoting signals to the nuc...
Genetic studies of melanocytic tumors have mainly demonstrated activation of oncogenes such as NRAS ...
Frequent somatic mutation of v-raf murine sarcoma viral oncogene homolog B (BRAF), a downstream effe...
There is increasing epidemiologic and molecular evidence that cutaneous melanomas arise through mult...
There is increasing epidemiologic and molecular evidence that cutaneous melanomas arise through mult...
Ras mutations, preferentially in codon 61 of the N-ras oncogene, are common in human cutaneous melan...
<div><p>According to the prevailing multistep model of melanoma development, oncogenic BRAF or NRAS ...